OTC Markets OTCQB - Delayed Quote USD
Algernon Pharmaceuticals Inc. (AGNPF)
0.0650
0.0000
(0.00%)
At close: May 14 at 3:59:53 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 4.36M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| Moreau (Christopher) Director of Issuer | Acquisition or disposition in the public market at price 0.06 per share. | Direct | 315 | Mar 27, 2025 |
| Moreau (Christopher) Director of Issuer | Acquisition or disposition in the public market at price 0.05 per share. | Direct | 106 | Mar 26, 2025 |
| Moreau (Christopher) Director of Issuer | -- | Indirect | -- | Mar 25, 2025 |
| Kinley (James F CA) Senior Officer of Issuer | -- | Indirect | -- | Mar 20, 2025 |
| Moreau (Christopher) Director of Issuer | -- | Indirect | -- | Mar 20, 2025 |
| Moreau (Christopher) Director of Issuer | Acquisition or disposition in the public market at price 0.06 per share. | Direct | 295 | Jan 9, 2025 |
| Moreau (Christopher) Director of Issuer | Acquisition or disposition in the public market at price 0.06 per share. | Direct | 855 | Nov 15, 2024 |
| Moreau (Christopher) Director of Issuer | Acquisition or disposition in the public market at price 0.06 per share. | Direct | 590 | Oct 7, 2024 |
| Kinley (James F CA) Senior Officer of Issuer | Acquisition or disposition in the public market at price 0.07 per share. | Direct | 1,320 | Sep 20, 2024 |
| Kinley (James F CA) Senior Officer of Issuer | Acquisition or disposition under a prospectus exemption at price 0.09 per share. | Indirect | 19,350 | Aug 1, 2024 |
| Moreau (Christopher) Director of Issuer | Acquisition or disposition under a prospectus exemption at price 0.09 per share. | Indirect | 36,378 | Aug 1, 2024 |
| Moreau (Christopher) Director of Issuer | Acquisition or disposition in the public market at price 0.08 per share. | Direct | 1,560 | Jun 27, 2024 |
| Moreau (Christopher) Director of Issuer | Acquisition or disposition in the public market at price 0.09 per share. | Direct | 396 | Jun 20, 2024 |
| Moreau (Christopher) Director of Issuer | Acquisition or disposition in the public market at price 0.10 per share. | Direct | 255 | Jun 5, 2024 |
| Moreau (Christopher) Director of Issuer | Acquisition or disposition in the public market at price 0.10 per share. | Direct | 1,224 | Jun 4, 2024 |
| Bryan (Christopher Scott) Senior Officer of Issuer | Acquisition or disposition in the public market at price 0.10 per share. | Direct | 2,111 | May 17, 2024 |
| Moreau (Christopher) Director of Issuer | Acquisition or disposition in the public market at price 0.10 per share. | Direct | 309 | May 17, 2024 |
| Moreau (Christopher) Director of Issuer | Acquisition or disposition in the public market at price 0.11 per share. | Direct | 2,889 | May 17, 2024 |
| Kinley (James F CA) Senior Officer of Issuer | Acquisition or disposition in the public market at price 0.09 per share. | Direct | 1,150 | May 16, 2024 |
Related Tickers
MSCLF Satellos Bioscience Inc.
0.4680
0.00%
XRTX.V XORTX Therapeutics Inc.
1.3500
-5.59%
RGBP Regen BioPharma, Inc.
0.0510
-0.20%
MDNAF Medicenna Therapeutics Corp.
0.7490
-0.13%
IPIX Innovation Pharmaceuticals Inc.
0.0001
0.00%
MOLN Molecular Partners AG
3.9101
-1.01%
RLFTF Relief Therapeutics Holding SA
2.5880
+6.94%
ONPH Oncology Pharma Inc.
0.0001
0.00%
EPRX Eupraxia Pharmaceuticals Inc.
3.9399
+1.81%
XRTX XORTX Therapeutics Inc.
0.9889
-0.11%